I’m three callers into the CC. The first two ask good important questions regarding how a dividend at this time, while ultimately rewarding to Gnbt shareholders, could be harmful to the company’s uplisting plans. Joe keeps saying he’s not sure and hasn’t concentrated on that that. That’s surprising. The third caller lecturing shareholders was a waste of time with his canibus question. Now I’ll listen to TC. Always a good listen.
We closed below $2? Well that’s exactly why shareholders get nervous when the ticker languishes at that cut off level on low volume.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links